Search Results - "Pungpapong, S"

Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study by Chascsa, D. M., Mousa, O. Y., Pungpapong, S., Zhang, N., Chervenak, A., Nidamanuri, S., Rodriguez, E., Franco, D., Ryland, K., Keaveny, A. P., Huskey, J. L., Smith, M., Reddy, K. S., Taner, C. B., Vargas, H. E., Aqel, B. A.

“…Waitlist time for kidney transplantation is long but may be shortened with the utilization of hepatitis C positive allografts. We retrospectively reviewed the…”
Get full text

Abatacept Use in Graft-Versus-Host Disease After Orthotopic Liver Transplantation: A Case Report by Elfeki, M.A, Genco, P.V, Pungpapong, S, Nakhleh, R.E, Nguyen, J.H, Harnois, D.M

“…Abstract Background Graft-versus-host disease (GVHD) is a rare, serious, fatal disease that occurs after orthotopic liver transplantation (OLT). Case Report We…”
Get full text

P878 MULTIVARIATE ANALYSIS OF FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE RATE OF PROTEASE INHIBITOR-BASED TREATMENT FOR RECURRENT HCV GENOTYPE 1 AFTER LIVER TRANSPLANTATION: MULTICENTER EXPERIENCE by Pungpapong, S, Aqel, B, Charlton, M, Vargas, H, Keaveny, A

Get full text

Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High‐Risk Recipients by Bosch, W., Heckman, M. G., Diehl, N. N., Shalev, J. A., Pungpapong, S., Hellinger, W. C.

“…In the era of effective antiviral chemoprophylaxis, cytomegalovirus (CMV) disease has been inconsistently associated with increased mortality in liver…”
Get full text

Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts by Curry, M, Modi, A.A, Pungpapong, S, Leise, M, Aqel, B, Llewellyn, J, Williams, L.A, Natha, M, Brainard, D.M, Kreter, B, Kholi, A, Wyles, D, Lee, Y, Reddy, R

Get full text

P870 REVERSIBLE NON-ISCHEMIC CARDIOMYOPATHY WITH SEVERE LEFT VENTRICULAR DYSFUNCTION AFTER LIVER TRANSPLANTATION by Yataco, M, Difato, T, Trejo-Gutierrez, J, Patel, T, Rosser, B, Bargehr, J, Pungpapong, S, Taner, B, Aranda-Michel, J

Get full text

P0851 : Effectiveness of sofosbuvir and ribavirin for genotype 2 and 3 HCV among non-cirrhotic, cirrhotic, and post-transplant patients at 3 US medical centers by Leise, M, Rodriguez, B, Pungpapong, S, Aqel, B, Chervenak, A, Werner, T, Murphy, J, Henry, T.M, Ryland, K, Keaveny, A, Vargas, H, Watt, K

Get full text

Choice of Partial Splenic Embolization Technique in Liver Transplant Recipients Correlates With Risk of Infectious Complications by Elfeki, M.A, Paz-Fumagalli, R, Tiemeier, A.M, Pungpapong, S, Sella, D.M, Frey, G.T, Musto, K.R, Nguyen, J.H, Harnois, D.M

“…Abstract Background Complications of cirrhosis may persist after liver transplantation. When indicated, partial splenic embolization (PSE) is an alternative to…”
Get full text

Liver Transplantation in Patients With Atrial Fibrillation by Bargehr, J, Trejo-Gutierrez, J.F, Rosser, B.G, Patel, T, Yataco, M.L, Pungpapong, S, Taner, C.B, Aranda-Michel, J

“…Abstract In this study we described survival and incidence of perioperative and postoperative complications in liver transplant recipients with known atrial…”
Get full text

Evaluation of risk factors for cytomegalovirus infection and disease occurring within 1 year of liver transplantation in high-risk patients by Katsolis, J.G., Bosch, W., Heckman, M.G., Diehl, N.N., Shalev, J.A., Pungpapong, S., Gonwa, T.A., Hellinger, W.C.

“…Background Recent studies have demonstrated that cytomegalovirus (CMV) infection and disease are associated with increased risk of graft loss and death in…”
Get full text

Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy by Bosch, W., Poowanawittayakom, N., Chaikriangkrai, K., Mendez, J., Hellinger, W.C., Gonwa, T.A., Krishna, M., Pungpapong, S.

“…Mycobacterium tuberculosis infection is one of many opportunistic infections in renal transplant recipients, arising either from reactivation of latent…”
Get full text

199 IS OBESITY ASSOCIATED WITH AN INCREASED RISK OF MORBIDITY AND MORTALITY IN PATIENTS WITH END-STAGE LIVER DISEASE REFERRED FOR LIVER TRANSPLANTATION? by DiTeodoro, L, McNeil, R, Dickson, R, Pungpapong, S, Aranda-Michel, J, Keaveny, A

Get full text

Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices by Pungpapong, S, Keaveny, A, Raimondo, M, Dickson, R, Woodward, T, Harnois, D, Wallace, M

“…Advances in endoscope design have allowed high-quality imaging using small-caliber endoscopes (< 6 mm), and these have been proposed as providing an accurate…”
Get more information

28 EMTRICITABINE/TENOFOVIR DF COMBINATION +/− HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS by Teperman, L, Spivey, J, Poordad, F, Schiano, T, Bzowej, N, Pungpapong, S, Martin, P, Coombs, D, Hirsch, K.R, Anderson, J, Rousseau, F

Get full text

The impact of diabetes and obesity on liver histology in patients with hepatitis C by Friedenberg, F., Pungpapong, S., Zaeri, N., Braitman, L. E.

“…Aim:  An association between diabetes mellitus and HCV has been recognized previously. No study has examined whether there is an independent association…”
Get full text

The role of surveillance endoscopy and endosonography after endoscopic ablation of high-grade dysplasia and carcinoma of the esophagus by Savoy, A. D., Wolfsen, H. C., Raimondo, M., Woodward, T. A., Noh, K., Pungpapong, S., Hemminger, L. L., Wallace, M. B.

“…Barrett's esophagus (BE) with high‐grade dysplasia (HGD) or early carcinoma treated with surgery or photodynamic therapy (PDT) is at risk of recurrence. The…”
Get full text

8 versus 12 Week Complete Viral Suppression After Heart Transplantation from Hepatitis C Positive Donors in Hepatitis C Negative Recipients by Jang, J., Pungpapong, S., Forshey-Friedman, J., Patel, P., Krishnarao, K., Yip, D.S., Leoni-Moreno, J., Nativi-Nicolau, J., Goswami, R.

“…Current research demonstrates acceptable rates of survival in patients receiving heart transplants from hepatitis c positive donors. The use of direct acting…”
Get full text

SAT-214 - Realworld Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) in Treatment-Experienced Cirrhotic Genotype 1 Patients with Chronic Hepatitis C: A Comparative Analysis of Gilead Sponsored Trials with 4 Real-World Cohorts by Curry, M., Modi, A.A., Pungpapong, S., Leise, M., Aqel, B., Llewellyn, J., Williams, L.A., Natha, M., Brainard, D.M., Kreter, B., Kholi, A., Wyles, D., Lee, Y., Reddy, R.

Get full text

Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation by BOSCH, Wendelyn, HECKMAN, Michael G, PUNGPAPONG, Surakit, DIEHL, Nancy N, SHALEV, Jefree A, HELLINGER, Walter C

“…Cytomegalovirus (CMV) has been inconsistently associated with recurrent hepatitis C virus (HCV) after liver transplant (LT). A retrospective study of 347,…”
Get full text

Perceptions of Gastroenterology Fellows Regarding ERCP Competency and Training by Kowalski, Thomas, Kanchana, Thirumaleshwar, Pungpapong, Surakit

“…The adequacy of ERCP training in the United States may be suboptimal because many training programs do not provide fellows with the exposure to the procedures…”
Get full text